Renaissance Capital logo

Sage Therapeutics Priced, Nasdaq: SAGE

Developing treatments for life-threatening epileptic seizures.

Industry: Health Care

First Day Return: +67.2%

Industry: Health Care

Developing treatments for life-threatening epileptic seizures.
more less
IPO Data
IPO File Date 06/17/2014
Offer Price $18.00
Price Range $17.00 - $18.00
Offer Shares (mm) 5.0
Deal Size ($mm) $90
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 07/17/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $90
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Cambridge, MA, United States
Founded 2010
Employees at IPO 25
Website www.sagerx.com

Sage Therapeutics (SAGE) Performance